-
Symbol
-
TRVI on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value per share
-
Latest Disclosed Ownership
-
8.51M shares
-
Security Ownership
-
7%
Frazier Life Sciences Public Fund, L.P. ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)
2025-11-14 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.51M shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI).
This represents 7% percent ownership of the company.
In their previous filing dated 2025-05-15, Frazier Life Sciences Public Fund, L.P. had reported owning 10.3M shares, indicating a decrease of -17.1% percent.